Treatment of Epileptic Encephalopathies

[1]  C. Ferrie,et al.  Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. , 2015, The Cochrane database of systematic reviews.

[2]  I. Scheffer,et al.  Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. , 2013, Brain : a journal of neurology.

[3]  L. Kaczmarek,et al.  De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy , 2012, Nature Genetics.

[4]  P. Striano,et al.  First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome). , 2012, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[5]  I. Scheffer,et al.  Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy , 2012, Epilepsia.

[6]  N. Fejerman,et al.  Sulthiame add‐on therapy in children with focal epilepsies associated with encephalopathy related to electrical status epilepticus during slow sleep (ESES) , 2012, Epilepsia.

[7]  E. Kossoff,et al.  Efficacy of the ketogenic diet in Lennox–Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literature , 2012, Developmental medicine and child neurology.

[8]  C. Tassinari,et al.  Therapy of encephalopathy with status epilepticus during sleep (ESES/CSWS syndrome): an update , 2012, Epileptic disorders : international epilepsy journal with videotape.

[9]  M. Staudt,et al.  Bromide in Patients with SCN1A-Mutations Manifesting as Dravet Syndrome , 2012, Neuropediatrics.

[10]  O. Dulac,et al.  Epilepsy: Genetics of early-onset epilepsy with encephalopathy , 2012, Nature Reviews Neurology.

[11]  I. Scheffer,et al.  Long‐term follow‐up of febrile infection–related epilepsy syndrome , 2012, Epilepsia.

[12]  F. Vigevano,et al.  Myoclonic astatic epilepsy: An age-dependent epileptic syndrome with favorable seizure outcome but variable cognitive evolution , 2011, Epilepsy Research.

[13]  M. Sahin,et al.  Febrile infection–related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome , 2011, Epilepsia.

[14]  M. Kokaia.  Light‐activated channels in acute seizures , 2011, Epilepsia.

[15]  C. V. van Karnebeek,et al.  Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. , 2011, Molecular genetics and metabolism.

[16]  I. Scheffer,et al.  De novo SCN1A mutations in migrating partial seizures of infancy , 2011, Neurology.

[17]  J. Osborne,et al.  The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study , 2011, Epilepsia.

[18]  E. Kossoff.  The Fat is in the Fire: Ketogenic Diet for Refractory Status Epilepticus , 2011, Epilepsy Currents.

[19]  R. Caraballo.  Nonpharmacologic treatments of Dravet syndrome: Focus on the ketogenic diet , 2011, Epilepsia.

[20]  T. Resnick,et al.  All children who experience epileptic falls do not necessarily have Lennox-Gastaut syndrome... but many do. , 2011, Epileptic disorders : international epilepsy journal with videotape.

[21]  B. Falck,et al.  The effect of surgery in encephalopathy with electrical status epilepticus during sleep , 2011, Epilepsia.

[22]  J. R. Hughes.  A review of the relationships between Landau–Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike–waves during sleep , 2011, Epilepsy & Behavior.

[23]  A. Marson,et al.  Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review , 2010, Epilepsia.

[24]  E. Kossoff,et al.  Doose syndrome (myoclonic–astatic epilepsy): 40 years of progress , 2010, Developmental medicine and child neurology.

[25]  L. Vallée,et al.  Infantile epileptic encephalopathy with late‐onset spasms: Report of 19 patients , 2010, Epilepsia.

[26]  C. Marcuccilli,et al.  Efficacy of felbamate in the treatment of intractable pediatric epilepsy. , 2010, Pediatric neurology.

[27]  J. H. Cross,et al.  Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009 , 2010, Epilepsia.

[28]  B. Weschke,et al.  Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. , 2010, Brain : a journal of neurology.

[29]  M. Baulac,et al.  Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin , 2009, CNS drugs.

[30]  J. H. Cross,et al.  The surgical treatment of Landau‐Kleffner syndrome , 2009, Epilepsia.

[31]  A. Munnich,et al.  Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts , 2009, Clinical genetics.

[32]  O. Dulac,et al.  Corticosteroids as treatment of epileptic syndromes with continuous spike‐waves during slow‐wave sleep , 2009, Epilepsia.

[33]  E. Gaily,et al.  Visual fields at school‐age in children treated with vigabatrin in infancy , 2009, Epilepsia.

[34]  M. Ruberg,et al.  Sporadic Infantile Epileptic Encephalopathy Caused by Mutations in PCDH19 Resembles Dravet Syndrome but Mainly Affects Females , 2009, PLoS genetics.

[35]  J. Cross,et al.  Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology , 2009, Lancet Neurology.

[36]  J. Cross,et al.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.

[37]  G. Krauss,et al.  Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome , 2008, Neurology.

[38]  Naomichi Matsumoto,et al.  De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy , 2008, Nature Genetics.

[39]  Shinji Saitoh,et al.  A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome). , 2007, American journal of human genetics.

[40]  A. Barkovich,et al.  Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus , 2007, Neurology.

[41]  E Wyllie,et al.  Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings , 2007, Neurology.

[42]  M. Baumgartner,et al.  Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy , 2007, Journal of Inherited Metabolic Disease.

[43]  Janez Stare,et al.  The Risk of Lower Mental Outcome in Infantile Spasms Increases after Three Weeks of Hypsarrhythmia Duration , 2006, Epilepsia.

[44]  N. Fejerman,et al.  Ketogenic diet in patients with myoclonic-astatic epilepsy. , 2006, Epileptic disorders : international epilepsy journal with videotape.

[45]  J. Tolmie,et al.  CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients , 2006, Journal of Medical Genetics.

[46]  J. Osborne,et al.  The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial , 2005, The Lancet Neurology.

[47]  L. Lagae,et al.  Steroids in intractable childhood epilepsy: Clinical experience and review of the literature , 2005, Seizure.

[48]  D. Kwiatkowski,et al.  Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex , 2005, Neurology.

[49]  A. Munnich,et al.  Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. , 2005, American journal of human genetics.

[50]  S. Shinnar,et al.  Long‐term Cognitive Outcomes of a Cohort of Children with Cryptogenic Infantile Spasms Treated with High‐dose Adrenocorticotropic Hormone , 2004, Epilepsia.

[51]  P. Veggiotti,et al.  Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial , 2002, Epilepsy Research.

[52]  S. Ohtahara,et al.  Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases , 2002, Brain and Development.

[53]  L. Lagae,et al.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. , 2001, American journal of human genetics.

[54]  T. Glauser.  Topiramate in the Catastrophic Epilepsies of Childhood , 2000, Journal of child neurology.

[55]  O. Dulac,et al.  Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial , 2000, The Lancet.

[56]  Naoyuki Kitamura,et al.  Successful control with bromide of two patients with malignant migrating partial seizures in infancy , 2000, Brain and Development.

[57]  H. Takada,et al.  Neurotrophin-3 Levels in Cerebrospinal Fluid From Children With Bacterial Meningitis, Viral Meningitis, or Encephalitis , 2000, Journal of child neurology.

[58]  R. Asarnow,et al.  Developmental outcomes in children receiving resection surgery for medically intractable infantile spasms , 1997, Developmental medicine and child neurology.

[59]  E. Oka,et al.  The early-infantile epileptic encephalopathy with suppression-burst: Developmental aspects , 1987, Brain and Development.

[60]  俊輔 大田原,et al.  特異な年齢依存性てんかん性脳症The Early-Infantile Epileptic Encephalopathy with Suppression-Burstに関する研究 , 1976 .

[61]  H. Cross,et al.  Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. , 2007, The Cochrane database of systematic reviews.